Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Niccolò Morisi"'
Autor:
Gaetano Alfano, Niccolò Morisi, Camilla Ferri, Francesco Fontana, Silvia Giovanella, Giulia Ligabue, Giacomo Mori, Erica Franceschini, Annachiara Ferrari, Mariacristina Gregorini, Gianni Cappelli, Sara Tagliazucchi, Monica Pecorari, Giovanni Guaraldi, Riccardo Magistroni, Gabriele Donati
Publikováno v:
Renal Replacement Therapy, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract Background The weakened immune system of patients on hemodialysis (HD) may prolong SARS-CoV-2 infection compared to the general population. Current international guidelines recommend ending isolation in conjunction with serial testing in mod
Externí odkaz:
https://doaj.org/article/fc291f26c1ab4bbb9d5d9747e44e98e6
Autor:
Grazia Maria Virzì, Niccolò Morisi, Davide Marturano, Sabrina Milan Manani, Ilaria Tantillo, Claudio Ronco, Monica Zanella
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 8, p 4284 (2024)
Erythrocytes (RBCs) have a highly specialized and organized membrane structure and undergo programmed cell death, known as eryptosis. Our preliminary data show a significant increase in the eryptosis during peritoneal dialysis (PD)-associated periton
Externí odkaz:
https://doaj.org/article/a2192b09665840ac88ff27b8e1eb3f54
Autor:
Gaetano Alfano, Monica Frisina, Niccolò Morisi, Elisabetta Ascione, Francesco Fontana, Giacomo Mori, Caterina Cerami, Francesco Serra, Francesca Cabry, Decenzio Bonucchi, Roberta Gelmini, Giovanni Guaraldi, Riccardo Magistroni, Gianni Cappelli
Publikováno v:
Case Reports in Nephrology and Dialysis, Vol 11, Iss 3, Pp 281-285 (2021)
Staphylococcus aureus is a Gram-positive bacterium commonly associated with severe infections in hospitalized patients. S. aureus produces many virulence factors leading to local and distant pathological processes. Invasiveness of S. aureus generally
Externí odkaz:
https://doaj.org/article/645124c087584ab7a7e2ea48ddbc58d5
Autor:
Gaetano Alfano, Roberta Scarmignan, Niccolò Morisi, Francesco Fontana, Silvia Giovanella, Giulia Ligabue, Laura Rofrano, William Gennari, Monica Pecorari, Mariacristina Gregorini, Gianni Cappelli, Riccardo Magistroni, Gabriele Donati
Publikováno v:
International Journal of Nephrology, Vol 2022 (2022)
Introduction. Patients receiving in-center hemodialysis are extremely vulnerable to COVID-19. It is unclear if routine screening of asymptomatic hemodialysis patients is an effective strategy to prevent COVID-19 outbreaks within the dialysis unit. Me
Externí odkaz:
https://doaj.org/article/d5974f61c06e44c0bf70ee3b8bfe11cd
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Traditional vaccination strategies had poor effectiveness in host response in haemodialysis (HD) patients [1]. That is why a booster dose of SARS-CoV-2 vaccine is highly recommended to prevent worse outcomes. The aim of the study
Autor:
Gaetano Alfano, Francesco Fontana, Niccolò Morisi, Gianni Cappelli, Riccardo Magistroni, Gabriele Donati
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS A great amount of information has been divulged on the epidemiology and outcome of coronavirus disease 2019 (COVID-19) in patients with ESRD. The majority of the studies have been conducted in patients on maintenance hemodialysis
Autor:
Gaetano Alfano, Francesco Fontana, Niccolò Morisi, Roberta Scarmignan, Laura Tonelli, Gianni Cappelli, Riccardo Magistroni, Gabriele Donati
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS mRNA-1273 vaccine (previously known as vaccine Moderna) has shown 94.1% efficacy at preventing COVID-19 illness in the general population. Vaccine-related adverse events (AEs) were usually mild or moderate in intensity and resolve
Autor:
Gaetano Alfano, Francesco Fontana, Annachiara Ferrari, Niccolò Morisi, Mariacristina Gregorini, Gianni Cappelli, Riccardo Magistroni, Giovanni Guaraldi, Gabriele Donati
Safe and timely discontinuation of quarantine of in-center hemodialysis (HD) patients with a previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a challenging issue for the nephrological community because current guidel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b037ef34f1bde1083cc789ad1b231cae
https://hdl.handle.net/11380/1293767
https://hdl.handle.net/11380/1293767
Autor:
Gaetano, Alfano, Niccolò, Morisi, Monica, Frisina, Annachiara, Ferrari, Francesco, Fontana, Roberto, Tonelli, Erica, Franceschini, Marianna, Meschiari, Gabriele, Donati, Giovanni, Guaraldi
Publikováno v:
Infez Med
COVID-19 is an unpredictable infectious disease caused by SARS-CoV-2. The development of effective anti-COVID-19 vaccines has enormously minimized the risk of severe illness in most immunocompetent patients. However, unvaccinated patients and non-res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cc96ac5210dfedf0d3ca63972190bed
https://hdl.handle.net/11380/1277100
https://hdl.handle.net/11380/1277100
Autor:
Gabriele Donati Prof., Martina Montani, Gianni Cappelli Prof., Roberta Scarmignan, Silvia Giovanella, Giulia Ligabue, Erica Franceschini, Niccolò Morisi, Laura Tonelli, Fontana Francesco Prof., Gaetano Alfano, Ferri Camilla, Riccardo Magistroni Prof., Giacomo Mori, Giovanni Guaraldi Prof.
IntroductionSome hemodialysis patients are reluctant to COVID-19 for the development of adverse events (AEs). The aim of this study was to verify the safety of mRNA-1273 vaccine in hemodialysis patients.MethodsWe conducted a retrospective analysis of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fc4d0d45fed2e340b67edb64b2a8b82
https://doi.org/10.1101/2021.11.21.21266561
https://doi.org/10.1101/2021.11.21.21266561